Dr. Messersmith acknowledges the physical and emotional challenges caused by cancer are only exacerbated by financial stress when patients are unable to work which is why the WeCanWork project has such great potential.
Because Sarcoma is a rare and unique disease, Dr. Wilky discusses the importance of partnering with researchers and clinicians across different disciplines to ensure patients receive a customized treatment plan and specialized care.
Diverse clinical-trial participation means better science, different groups of people may respond to a given medication in different ways including efficacy and side effects. When certain populations are underrepresented in medical research, the result can be further health disparities.
On May 11, survivors of lung cancer for five years or more gathered on the CU Anschutz Medical Campus with clinicians, researchers, and staff members in the CU Thoracic Oncology Program to celebrate with other survivors.